Differing indications

Seid, Cherinet
September 2009
CMAJ: Canadian Medical Association Journal;9/1/2009, Vol. 181 Issue 5, pE85
Academic Journal
The article discusses the developments in the treatment of people having HIV and AIDS in Ethiopia. It notes there are centres in Addis Ababa, the capital city, offering HIV care which includes highly-active antiretroviral treatment. According to the article, the establishment of highly-active antiretroviral treatment was a collaboration between the Ethiopian government and various international organizations.


Related Articles

  • Immediate ART in HIV patients prevented infection in partners.  // Infectious Disease News;Jun2011, Vol. 24 Issue 6, p15 

    The article reports on a study which revealed that HIV-infected people who initiated immediate oral antiretroviral therapy were less likely to infect their uninfected partners and remained healthier than those assigned delayed treatment.

  • Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods.  // BMC Public Health;2012, Vol. 12 Issue 1, p296 

    The article presents the findings of a research conducted on examining the risk of HIV transmission in a person on ART. It mentions that this PARTNER study is an international and observational study taking place from 2010 to 2014, in which HIV serodifferent partnerships who at enrolment...

  • Management of HIV infected patients with assisted reproductive techniques. Bhana, M.; Naidu, S. // Obstetrics & Gynaecology Forum;Aug2011, Vol. 21 Issue 3, p16 

    The use of HAART (Highly Active Antiretroviral Therapy) has significantly decreased the morbidity and mortality in individuals infected with HIV. Many couples who are infected with HIV (sero-discordant and sero-concordant) seek assistance with conception. The objective of the paper is to address...

  • Current perspectives in HIV post-exposure prophylaxis. Sultan, Binta; Benn, Paul; Waters, Laura // HIV/AIDS - Research & Palliative Care;2014, Vol. 6, p147 

    The incidence of human immunodeficiency virus (HIV) infection continues to rise among core groups and efforts to reduce the numbers of new infections are being redoubled. Post-exposure prophylaxis (PEP) is the use of short-term antiretroviral therapy (ART) to reduce the risk of acquisition of...

  • Editorial Commentary: Universal Antiretroviral Therapy for HIV Infection? Lundgren, Jens D.; Wood, Robin // Clinical Infectious Diseases;Sep2013, Vol. 57 Issue 6, p888 

    The article focuses on the benefit of antiretroviral therapy (ART) in the Human immunodeficiency virus (HIV) infected person under clinical trial conditions to stop the progression of HIV disease. It informs that untreated HIV infection activates host inflammatory processes which cause cancers....

  • Universal Testing and Treatment as an HIV Prevention Strategy: Research Questions and Methods. Hayes, Richard; Sabapathy, Kalpana; Fidler, Sarah // Current HIV Research;Sep2011, Vol. 9 Issue 6, p429 

    Achieving high coverage of antiretroviral treatment (ART) in resource-poor settings will become increasingly difficult unless HIV incidence can be reduced substantially. Universal voluntary counselling and testing followed by immediate initiation of ART for all those diagnosed HIV-positive...

  • Trends in Multidrug Treatment Failure and Subsequent Mortality among Antiretroviral Therapy-Experienced Patients with HIV Infection in North America. Deeks, Steven G.; Gange, Stephen J.; Kitahata, Mari M.; Saag, Michael S.; Justice, Amy C.; Hogg, Robert S.; Eron, Joseph J.; Brooks, John T.; Rourke, Sean B.; Gill, M. John; Bosch, Ronald J.; Benson, Constance A.; Collier, Ann C.; Martin, Jeffrey N.; Klein, Marina B.; Jacobson, Lisa P.; Rodriguez, Benigno; Sterling, Timothy R.; Kirk, Gregory D.; Napravnik, Sonia // Clinical Infectious Diseases;11/15/2009, Vol. 49 Issue 10, p1582 

    Background. Although combination antiretroviral therapy continues to evolve, with potentially more effective options emerging each year, the ability of therapy to prevent multiple regimen failure and mortality in clinical practice remains poorly defined. Methods. Sixteen cohorts representing...

  • Update in HIV Medicine for the Generalist. Chaudhry, Amina A.; Gifford, Allen L.; Cofrancesco Jr., Joseph; Sosman, James; Berkenblit, Gail; Sullivan, Lynn E. // JGIM: Journal of General Internal Medicine;Feb2009, Vol. 24 Issue 2, p276 

    The article presents studies on the prevention and management of HIV infection. R. H. Gray and colleagues performed randomized controlled trials in Rakai, Uganda to assess safety of male circumcision in reducing HIV transmission. A. D. Paltiel and colleagues applied cost-effectiveness modeling...

  • Safety, Tolerability and Effectiveness of Generic HAART in HIV-Infected Children in South India. N. Kumarasamy; Kartik K. Venkatesh; Bella Devaleenol; S. Poongulali; S. N. Mothi; Suniti Solomon // Journal of Tropical Pediatrics;Jun2009, Vol. 55 Issue 3, p155 

    HIV-infected children in resource-limited settings are increasingly gaining greater access to highly active antiretroviral therapy (HAART) but documented longitudinal data remains limited. We aimed to study the clinical and immunological outcomes among 67 South Indian HIV-infected children with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics